Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 25,417 US PATENTS IN FORCE
- 47,284 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 218,596 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| RE49948 | Aryl ethers and uses thereof | Feb 03, 22 | Apr 30, 24 | Peloton Therapeutics, Inc. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0164,410 | A STABLE, EMULSION-FORMING LIQUID COMPOSITION COMPRISING AMINO ACIDS | Mar 25, 22 | May 23, 24 | Not available |
| 2024/0165,012 | COMBINATION OF PLANT EXTRACTS TO IMPROVE SKIN TONE | Nov 22, 23 | May 23, 24 | Not available |
| 2024/0165,018 | HYDROGEL IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE | Oct 27, 23 | May 23, 24 | Not available |
| 2024/0165,050 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | Sep 13, 23 | May 23, 24 | Not available |
| 2024/0165,054 | TREATMENT | Jan 26, 24 | May 23, 24 | Not available |
| 2024/0165,058 | FORMULATIONS FOR HAIR GROWTH | Oct 23, 23 | May 23, 24 | Not available |
| 2024/0165,060 | METHOD AND COMPOSITION FOR LOWERING TOTAL SYSTEMIC CHOLESTROL, LDL CHOLESTEROL, AND NON-HDL CHOLESTEROL | Feb 02, 24 | May 23, 24 | Biokier, Inc. |
| 2024/0165,062 | COMPOSITION FOR INCREASING MUSCLE | Aug 28, 23 | May 23, 24 | Yuki Gosei Kogyo Co Ltd.; KYUSHU UNIVERSITY - NATIONAL UNIVERSITY CORPORATION; |
| 2024/0165,066 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | Sep 22, 23 | May 23, 24 | Not available |
| 2024/0165,070 | GLUTAMINASE INHIBITOR THERAPY | Sep 06, 23 | May 23, 24 | Not available |
| 2024/0165,072 | PHARMACEUTICAL COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS THROUGH INFLAMMATION AMELIORATION OF HUMAN DERMAL PAPILLA CELLS AND PERIPHERAL CELLS AND INHIBITION OF 5A-REDUCTASE EXPRESSION | Mar 22, 22 | May 23, 24 | Not available |
| 2024/0165,074 | COMPOSITION OF THE PHYTOCOMPOUNDS INTENDED TO ENHANCE CYTOTOXIC ACTIVITY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA | Feb 10, 22 | May 23, 24 | Not available |
| 2024/0165,078 | THERAPEUTIC TARGETING OF RECEPTOR TYROSINE KINASE INHIBITOR-INDUCED ANDROGEN RECEPTOR PHOSPHORYLATION IN CANCER | Jan 31, 24 | May 23, 24 | Not available |
| 2024/0165,080 | PSILOCIN MUCATE | Jan 12, 24 | May 23, 24 | Not available |
| 2024/0165,082 | ORALLY ADMINISTERED COMPOSITIONS FOR CANCER TREATMENT | Oct 27, 23 | May 23, 24 | Not available |
| 2024/0165,084 | ASCORBIC ACID AND QUINONE COMPOUNDS IN COMBINATION WITH AN ANTIPARASITIC AGENT FOR TREATING A PARASITIC DISEASE | Jan 15, 24 | May 23, 24 | Not available |
| 2024/0165,090 | METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW HEMATOPOIETIC FUNCTIONS | Oct 16, 20 | May 23, 24 | Not available |
| 2024/0165,092 | USE OF AN OREXIN 2 RECEPTOR AGONIST FOR POST OPERATION RECOVERY | Apr 01, 22 | May 23, 24 | Not available |
| 2024/0165,094 | METHODS AND COMPOSITIONS FOR TREATING MELANOMA | Mar 16, 22 | May 23, 24 | Not available |
| 2024/0165,096 | Anti Viral Therapy | Mar 18, 22 | May 23, 24 | Not available |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)